Diabetes Enhances Lipopolysaccharide-Induced Cardiac Toxicity in the Mouse Model

Cardiovascular Toxicology

Volumn 3, Issue 4, 2003, Pages 363-372

  Song, Ye ^a   Song, Zhenyuan ^a   Zhang, Li ^a   McClain, Craig J ^a,b   Kang, Y James ^a,c   Cai, Lu ^a  

^a University of Louisville School of Medicine   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Cytokines; Diabetic cardiotoxicity; Endotoxin; Inflammatory factors; Interleukin 6; Mouse troponin T; Tumor necrosis factor

Indexed keywords

3 NITROTYROSINE; CREATINE KINASE; ENDOTOXIN; EOSIN; GLYCOSYLATED HEMOGLOBIN; HEART ENZYME; HEMATOXYLIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PROTEIN; STREPTOZOCIN; TRIACYLGLYCEROL; TROPONIN T; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CARDIOVASCULAR SYSTEM; CELL STRUCTURE; CHRONIC DISEASE; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FRIEND LEUKEMIA VIRUS; HEART; HYPOTHESIS; INFLAMMATION; MALE; MICROSCOPY; MOUSE; NONHUMAN; OXIDATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEPTICEMIA; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ANIMALS; CREATINE KINASE; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED STRAINS; MYOCARDIUM; SEPSIS; TRIGLYCERIDES; TROPONIN T; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; FRIEND MURINE LEUKEMIA VIRUS;

EID: 0346727410     PISSN: 15307905     EISSN: None     Source Type: Journal    
DOI: 10.1385/CT:3:4:363     Document Type: Article

References (38)

1. Lewis, J. and Fekety, F.R. Jr. (1969). Gram-negative bacteremia. Johns Hopkins Med. J. 124:106-111.
2. Rajbhandari, S.M. and Wilson, R.M. (1988). Unusual infections in diabetes. Diabetes Res. Clin. Pract. 39:123-128.
3. Sarnak, M.J. and Jaber, B.L. (2000). Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int. 58:1758-1764.
4. Law, W.R., Moriarty, M.T., and McLane, M.P. (1991). Cardiovascular sequelae of endotoxin shock in diabetic dogs. Diabetologia 34:687-694.
5. Parillo, J.E. (1993). Pathogenetic mechanisms of septic shock. N. Engl. J. Med. 328:1471-1477.
6. Lowe, G.D. (2000). The relationship between infection, inflammation, and cardiovascular disease: an overview. Ann. Periodontol. 6:1-8.
7. McCarty, M.F. (1999). Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline. Med. Hypotheses 52:465-477.
8. Ancey, C., Corbi, P., Froger, J., et al. (2002). Secretion of IL-6, IL-11 and LIF by human cardiomyocytes in primary culture. Cytokine 18:199-205.
9. Carey, A.L., Lamont, B., Andrikopoulos, S., Koukoulas, I., Proietto, J., and Febbraio, M.A. (2003). Interleukin-6 gene expression is increased in insulin-resistant rat skeletal muscle following insulin stimulation. Biochem. Biophys. Res. Commun. 302:837-840.
10. Matsui, H., Ihara, Y., Fujio, Y., et al. (1999). Induction of interleukin (IL)-6 by hypoxia is mediated by nuclear factor (NF)-kappa B and NF-IL6 in cardiac myocytes. Cardiovasc. Res. 42:104-112.
11. Lowbeer, C., Stenvinkel, P., Pecoits-Filho, R., et al. (2003). Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality. J. Intern. Med. 253:153-160.
12. Sano, M., Fukuda, K., Kodama, H., et al. (2000). Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes. J. Biol. Chem. 275:29717-29723.
13. Tanaka, T., Kanda, T., McManus, B.M., et al. (2001). Overexpression of interleukin-6 aggravates viral myocarditis: impaired increase in tumor necrosis factor-alpha. J. Mol. Cell. Cardiol. 33:1627-1635.
14. Giroir, B.P., Johnson, J.H., Brown, T., Allen, G.L., and Beutler, B. (1992). The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J. Clin. Invest. 90:693-698.
15. Meldrum, D.R. (1998). Tumor necrosis factor in the heart. Am. J. Physiol. 274:R577-R595.
16. Esposito, K., Nappo, F., Marfella, R., et al. (2002). Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106:2067-2072.
17. Depre, C., Young, M.E., Ying, J., et al. (2000). Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction. J. Mol. Cell. Cardiol. 32:985-996.
18. Grimble, R.F. (2002). Inflammatory status and insulin resistance. Curr. Opin. Clin. Nutr. Metab. Care 5:551-559.
19. Fauvel, H., Marchetti, P., Obert, G., et al. (2002). Protective effects of cyclosporin A from endotoxin-induced myocardial dysfunction and apoptosis in rats. Am. J. Respir. Crit. Care Med. 165:449-455.
20. Mann, D.L. (2002). Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ. Res. 91:988-998.
21. Natanson, C., Fink, M.P., Ballantyne, H.K., MacVittie, T.J., Conklin, J.J., and Parrillo, J.E. (1986). Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock. J. Clin. Invest. 78:259-270.
22. Archer, L.T., Beller, B.K., Drake, J.K., Whitsett, T.L., and Hinshaw, L.B. (1978). Reversal of myocardial dysfunction in endotoxin shock with insulin. Can. J. Physiol. Pharmocol. 56:132-138.
23. Tanaka, S., Seino, H., Satoh, J., et al. (1992). Increased in vivo production of tumor necrosis factor after development of diabetes in nontreated, long-term diabetic BB rats. Clin. Immunol. Immunopathol. 62:258-263.
24. Pickup, J.C., Chusney, G.D., Thomas, S.M., and Burt, D. (2000). Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci. 67:291-300.
25. Chawla, R.K., Watson, W.H., Eastin, C.E., Lee, E.Y., Schmidt, J., and McClain, C.J. (1998). S-adenosylmethionine deficiency and TNF-alpha in lipopolysaccharide-induced hepatic injury. Am. J. Physiol. 275:G125-G129.
26. Mair, J. (1997). Cardiac troponin I and troponin T: are enzymes still relevant as cardiac markers? Clin. Chim. Acta 257:99-115.
27. Metzler, B., Hammerer-Lercher, A., Jehle, J., et al. (2002). Plasma cardiac troponin T closely correlates with infarct size in a mouse model of acute myocardial infarction. Clin. Chim. Acta 325:87-90.
28. McDonough, K.H., Barbee, R.W., Dobrescu, C., Lang, C.H., and Spitzer, J.J. (1987). Enhanced myocardial depression in diabetic rats during E. coli sepsis. Am. J. Physiol. 253:H276-H282.
29. Tsutamoto, T., Hisanaga, T., Wada, A., et al. (1998). Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J. Am. Coll. Cardiol. 31:391-398.
30. Kanda, T., Inoue, M., Kotajima, N., et al. (2000). Circulating interleukin-6 and interleukin-6 receptors in patients with acute and recent myocardial infarction. Cardiology 93:191-196.
31. Plenz, G., Song, Z.F., Tjan, T.D., et al. (2001). Activation of the cardiac interleukin-6 system in advanced heart failure. Eur. J. Heart Fail. 3:415-421.
32. Wollert, K.C. and Drexler, H. (2001). The role of interleukin-6 in the failing heart. Heart Fail. Rev. 6:95-103.
33. Hirota, H., Yoshida, K., Kishimoto, T., and Taga, T. (1995). Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc. Natl. Acad. Sci. USA. 92:4862-4866.
34. Ito, H., Ono, K., Nishio, R., Sasayama, S., and Matsumori, A. (2002). Amiodarone inhibits interleukin 6 production and attenuates myocardial injury induced by viral myocarditis in mice. Cytokine 17:197-202.
35. Huber, S.A., Sakkinen, P., Conze, D., Hardin, N., and Tracy, R. (1999). Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 19: 2364-2367.
36. Jialal, I., Devaraj, S., and Venugopal, S.K. (2002). Oxidative stress, inflammation, and diabetic vasculopathies: the role of alpha tocopherol therapy. Free Radic. Res. 36: 1331-1336.
37. Dalla Libera, L., Sabbadini, R., Renken, C., et al. (2001). Apoptosis in the skeletal muscle of rats with heart failure is associated with increased serum levels of TNF-alpha and sphingosine. J. Mol. Cell. Cardiol. 33:1871-1878.
38. Kubota, T., Miyagishima, M., Frye, C.S., et al. (2001). Overexpression of tumor necrosis factor-alpha activates both anti- and pro-apoptotic pathways in the myocardium. J. Mol. Cell. Cardiol. 33:1331-1344.